Regeneron Pharmaceuticals Inc at BMO Capital Markets Prescription for Success Healthcare Conference (Virtual) Transcript
All right. Good morning, everyone. My name is Matthew Luchini, one of the biotech analysts here at BMO. Welcome to the Virtual Prescriptions for Success Conference, and to my portion of the fireside chat. It's my pleasure to welcome for my first fireside chat of today, Regeneron, and in particular, today, we have Justin Holko, Vice President of Investor Relations. Justin, it's a pleasure to have you here. Welcome. Let me go ahead and open it up to you for a few opening remarks, and we can go ahead and get started.
Great. Thank you, Matthew, and it's a pleasure to be joining you today. I think this is the first time we've joined your conference. And if not the first time, it's been quite a while. So thank you for the invitation. Just a reminder to everybody, we will be making some statements today that will be forward-looking in nature. For a full reading of all the risks and uncertainties associated with the business that could impact those
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
